Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Checkpoint Therapeutics Inc shares valued at $50,450 were sold by Oliviero James F III on Jun 26 ’24. At $2.05 per share, Oliviero James F III sold 24,610 shares. The insider’s holdings dropped to 1,977,170 shares worth approximately $6.8 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, GRAY WILLIAM GARRETT sold 13,038 shares, netting a total of over 26,858 in proceeds. Following the sale of shares at $2.06 each, the insider now holds 672,186 shares.
Before that, Oliviero James F III had sold 5,894 shares from its account. In a trade valued at $12,142, the CEO, President and Director traded Checkpoint Therapeutics Inc shares for $2.06 each. Upon closing the transaction, the insider’s holdings decreased to 5,894 shares, worth approximately $1.21 million.
Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 20, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for CKPT. Earlier on May 29, 2019, Lake Street initiated its rating. Their recommendation was “a Buy” for CKPT stock.
Analyzing CKPT Stock Performance
During the last five days, there has been a surge of approximately 15.82%. Over the course of the year, Checkpoint Therapeutics Inc shares have jumped approximately 50.22%. Shares of the company reached a 52-week high of $3.64 on 10/24/24 and a 52-week low of $1.38 on 05/01/24. A 50-day SMA is recorded $2.41, while a 200-day SMA reached $2.08. Nevertheless, trading volume fell to 2.03 million shares from 1.64 million shares the previous day.
Support And Resistance Levels for Checkpoint Therapeutics Inc (CKPT)
According to the 24-hour chart, there is a support level at 3.28, which, if violated, would cause prices to drop to 3.13. In the upper region, resistance lies at 3.62. The next price resistance is at 3.80. RSI (Relative Strength Index) is 83.99 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.54, which suggests the price will decrease in the coming days. Percent R is at 14.13%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of Checkpoint Therapeutics Inc (CKPT)?
On December 08, 2017, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $11.
